Medicine
New Study Reveals How Chemokines Bind to Receptors
Researchers at science advances have created detailed structures of chemokine-receptor interactions that shed light on how specific ligands bind and activate the receptor.
Illustration: Blue Dot News
1 min read
The molecular basis of CXC chemokine receptor 3 ligand multispecificity has been elucidated through a combination of cryo-electron microscopy and functional studies by the research team led by Bouyssou A et al. published in Science Advances. By determining the three-dimensional structures of all three chemokine-CXCR3-G i complexes, the researchers were able to visualize the binding interactions between these molecules.
The study reveals that CXCL9, CXCL10, and CXCL11 exhibit distinct pharmacological and interaction profiles, with varying efficacies and potencies. This variability is attributed to the critical role of the membrane-distal CXCR3 N terminus in ligand binding and signaling. The researchers utilized chimeric chemokines and molecular dynamics simulations to demonstrate the signaling plasticity of chemokine ligands and signaling determinants.
The proposed multimodal binding and activation framework explains CXCR3 chemokine ligand multispecificity and signaling versatility, providing a comprehensive understanding of how these molecules interact with their receptor. This work offers valuable insights into the complex interactions between chemokines and their receptors, enabling researchers to interrogate and modulate CXCR3 biology.
This discovery underscores the intricate relationships within the molecular world, where subtle variations in protein structure and function can lead to significant differences in biological outcomes. As we continue to unravel the mysteries of molecular recognition and signaling, we are reminded of our place within the vast universe of complexity that surrounds us.
1 min read
In the intricate dance of immune cells, a subtle balance is maintained by the specific interactions between chemokine receptors and their corresponding ligands. For years, scientists have been fascinated by the CXC chemokine receptor 3 (CXCR3) and its unique ability to bind multiple ligands with varying degrees of efficacy. Like skilled musicians tuning their instruments, researchers Bouyssou A et al. have carefully crafted a detailed understanding of how CXCR3 interacts with its three primary ligands: CXCL9, CXCL10, and CXCL11.
Through a combination of cutting-edge techniques such as cryo-electron microscopy and molecular dynamics, the team has been able to visualize and analyze the precise mechanisms by which these ligands bind to CXCR3. Their findings reveal that the membrane-distal N terminus of CXCR3 plays a critical role in determining the specificity and potency of these interactions. This discovery offers new insights into the complex signaling pathways activated by CXCR3, shedding light on its versatility as a receptor.
So why does this matter? The intricate balance maintained by CXCR3 and its ligands is essential for our immune system's ability to respond effectively to infection and inflammation. Dysregulation of these interactions has been implicated in various diseases, including autoimmune disorders and cancers. By gaining a deeper understanding of the molecular mechanisms underlying CXCR3 biology, researchers can develop new therapeutic strategies to target these complex processes and improve human health.
1 min read
Imagine a tiny door on the surface of a cell that opens to let in special messengers from outside. These messengers are like tiny keys that fit perfectly into a lock on the cell door, and when they do, it triggers a response inside the cell. Scientists have been studying these messengers and their locks for a long time, trying to figure out how they work together.
Recently, researchers discovered the secret code to unlocking the doors of many different types of cells, all at once. They used a powerful tool called cryo-electron microscopy to see what the keys looked like when they fit into the lock. What they found was that some keys fit in slightly different ways than others, and that's why some responses work better for one type of cell than another. This discovery helps us understand how our bodies respond to different signals from the outside world, and it could lead to new treatments for diseases.
The people behind the work
-
Bouyssou A et al.
Author
Published in Science advances
Source: Science advances
Sources & Verification
Every statement in this story is drawn from the facts below. Each is linked to a primary or reputable source — follow any citation to check it for yourself.
- Here, we present cryo-electron microscopy structures of all three chemokine-CXCR3-G i complexes, complemented by cell binding studies and functional mutagenesis data. Science advances
- We systematically compare the pharmacological and interaction profiles of CXCL9, CXCL10, and CXCL11 to rationalize their varying efficacies and potencies and to reveal the critical role of the membrane-distal CXCR3 N terminus in ligand binding and signaling. Science advances
- Using chimeric chemokines and molecular dynamics, we reveal the signaling plasticity of chemokine ligands and signaling determinants. Science advances
- Together, these insights enable us to propose a multimodal binding and activation framework that explains CXCR3 chemokine ligand multispecificity and signaling versatility and offer tools to interrogate and modulate CXCR3 biology. Science advances
Part of the Blue Dot News 2026 retrospective — an archive reconstructed automatically from the published scientific record. The science is real and cited above; this is not original daily reporting, and it is deliberately kept out of the live news feed.